Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

MINOCYCLINE HCL

All products: general benefit

Other products in the same Health Canada class (J01AA) — coverage varies; not interchangeable

  • Doxycycline hyclate (PMS-Doxycycline): general benefit, Not a benefit
  • Tetracycline (Tetracyn): general benefit, Not a benefit
  • Tigecycline (Tygacil): general benefit
  • Doxycycline (Apprilon): not a benefit

Minocycline · DIN 02084104 · 100mg · capsule

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Minocycline · DIN 02084104 Manufacturer: A A Pharma Inc.; listing date 2008-01-15 Health Canada: Marketed since 2020-01-03 · brand MINOCYCLINE · ATC J01AA08 MINOCYCLINE · form Capsule · route Oral · ingredients MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) 100 MG · company Aa pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Minocycline: Formulary list price $1.0836/unit (unit not stated in source; not the patient's cost)

Ministry pays: $1.0836 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15925 · Verify on the e-Formulary ↗ (DIN 02084104)

Source record
DIN 02084104: Minocycline Raw flags: sec3=Y Item: 081224022; group id 33; item number 0069; lccId None; manufacturer id AAP Source form: Cap; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $1.0836; ministry $1.0836 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02084104 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15925
Interchangeable products
Minocin · DIN 02173506 · not recorded
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (08:12:24 Tetracyclines) and how they are covered

Matched class: 08:12:24 Tetracyclines

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: TIGECYCLINE Some products covered without a code (check the product listing): DOXYCYCLINE HYCLATE, TETRACYCLINE 08:12:24 Tetracyclines

DOXYCYCLINE HYCLATE

· 10 products · Off-Formulary Interchangeable, not an ODB benefit (2), Listed, not a benefit (1), General benefit (7) · strengths: 20mg, 100mg · Cap, Tab

TETRACYCLINE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 250mg · Cap

TIGECYCLINE

· 1 products · General benefit · strengths: 50mg/Vial · Pd for Inj-5mLVial Pk (Preservative-Free)

DOXYCYCLINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 40mg · MR Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:24
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATION AND CLINICAL USES MINOCYCLINE (minocycline hydrochloride) may be indicated for the treatment of the following infections due to susceptible strains of the designated organisms: Gall bladder infections caused by Escherichia coli. Urinary tract infections: cystitis, gonorrhea, pyelonephritis caused by Escherichia coli, Proteus species, Klebsiella species, Enterobacter aerogenes, Neisseria gonorrhoeae. When penicillin is contraindicated, minocycline may be employed as an alternative drug in the treatment of anal and pharyngeal gonorrhea and syphilis. Skin and soft tissue infections: abscess, cellulitis, furunculosis, impetigo and pyoderma caused by: Staphylococcus epidermidis. Staphylococcus aureus, Streptococcus pyogenes, Proteus Page 2 of 30 species, Escherichia coli. Although tetracyclines are not the drugs of choice in any staphylococcal or streptococcal infection minocycline could be useful in circumstances where these organisms are shown to be resistant to other agents but sensitive to minocycline. Bacterial evaluation of clinical cases invo… https://pdf.hres.ca/dpd_pm/00053334.PDF PM date: September 27, 2019 Source product: MINOCYCLINE; DIN 02084090; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.